Major Players - Canine Atopic Dermatitis Treatment Drugs Industry

 

It is anticipated that the increasing number of research and development activities to introduce various treatment treatments for canine atopic dermatitis will be a major driver driving the growth of the worldwide canine atopic dermatitis treatment medicines market in the near future. This growth is projected to occur due to the increasing prevalence of the condition. For example, in July of 2019, Kindred Biosciences, Inc., a clinical-stage biopharmaceutical company, announced positive results from its pilot study on the effectiveness of KIND-016, a fully caninized (anti-canine), high-affinity monoclonal antibody targeting interleukin-31 (IL-31), for the treatment of atopic dermatitis in dogs. KIND-016 is intended to treat atopic dermatitis in dogs.

The global Canine Atopic Dermatitis Treatment Drugs Market size is estimated to be valued at US$ 765 million in 2021 and is expected to witness a CAGR of 16.5% over the forecast period (2021-2028).

Leading Companies in the Canine Atopic Dermatitis Treatment Drugs Industry:

1) Elanco Animal Health Incorporated

Elanco Animal Health Incorporated is an American pharmaceutical company that is known for producing medicines and vaccinations for pets and livestock. It is the third-largest animal health company in the world. The company was founded in the year 1954, and the headquarters are located in Greenfield, Indiana, U.S.

In August 2021, Elanco completed the acquisition of Kindred Biosciences, a veterinary biotechnology company focused on developing innovative biologics and technologies to veterinary medicine.

2) Dechra Pharmaceuticals plc.

Dechra Pharmaceuticals Plc. is a company that develops and markets veterinary products. The company is listed in the London Stock Exchange and is a constituent of the FTSE 250 Index. Dechra was founded in the year 1997, and the headquarters are located in Northwich, England, U.K. It mainly sells pharmaceuticals for dogs, cats, equine and food producing animals.

3) Zoetis Inc.

Zoetis Inc. is an American drug company. It is the world’s largest producer of medicine and vaccinations for pets and livestock. Zoetis was a subsidiary of Pfizer, the world’s largest drug maker. The company was founded in the year 1952, and the headquarters are located in Parsippany, New Jersey, U.S.

In June 2022, Zoetis completed the acquisition of Basepaws, a privately held genetics company.

4) Virbac

Virbac is a French company that’s dedicated to animal health. The company is the 6^th largest veterinarian pharmaceutical group. Virbac was founded in the year 1968, and the headquarters are located in Carros, France. The company was founded by Pierre-Richard Dick. Products manufactured include Antibiotics, vaccines, dermatology, antiparasitics, and dental hygiene.

As of November 2021, Virbac completed the acquisition of Centrovet

5) Toray Industries, Inc.

Toray Industries Inc. is a multinational corporation that specializes in industrial products cantered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry. Its founding business areas were fibres and textiles, as well as plastics and chemicals. The company has also diversified into areas such as pharmaceuticals, biotechnology and R&D, medical products, reverse osmosis big membranes, electronics, IT-products, housing and engineering, as well as advanced composite materials. The company was founded in the year 1926, and the headquarters are located in Tokyo, Japan.

On January 2020, Toray Inc. announced that it completed procedures to acquire all of the issued and outstanding shares of Alva Sweden AB, a manufacturer of cushions for automotive airbag systems

6) Dechra Pharmaceuticals PLC,

 Dechra Pharmaceuticals PLC, Company founded in 1997, and it’s located Northwich, United Kingdom .The Company operates in 45 Countries.

7) Toray Industries, Inc.

Toray Industries, Inc Company founded in 1926, and it’s located Chuo City, Tokyo, Japan.The Company operates in 29 Countries. IN 2020 The company offers solutions for canine atopic dermatitis which have active ingredients such as canine interferon-y that are genetically .

Definition:

Canine atopic dermatitis (AD) has been defined as a genetically predisposed inflammatory and pruritic allergic skin disease of dogs and cats.